InsiderTrades.com logo

ACTU Insider Trading

Insider Ownership Percentage: 69.34%
Insider Buying (Last 12 Months): $1,499,988.00
Insider Selling (Last 12 Months): $0.00

Actuate Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Actuate Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Actuate Therapeutics Share Price & Price History

Current Price: $7.35
Price Change: ▼ Price Decrease of -0.08 (-1.08%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for ACTU up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Actuate Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/27/2025Aaron G.L. FletcherDirectorBuy71,428$7.00$499,996.00196,428View SEC Filing Icon  
6/27/2025Equity Cof Lp BiosDirectorBuy71,428$7.00$499,996.00196,428View SEC Filing Icon  
6/27/2025Leslie W KreisDirectorBuy71,428$7.00$499,996.00196,428View SEC Filing Icon  
8/14/2024Equity Cof Lp BiosDirectorBuy500,000$8.00$4,000,000.001,259,427View SEC Filing Icon  
8/14/2024Leslie W KreisMajor ShareholderSell24,999$9.00$224,991.00131,248View SEC Filing Icon  
8/14/2024Todd S ThomsonInsiderSell18,750$8.00$150,000.001,184,795View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Actuate Therapeutics (NASDAQ:ACTU)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ACTU by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Actuate Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/20/2025Voss Capital LP896,278$6M0.3%+213.2%3.857%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE4,872$33K0.0%-68.1%0.021%Search for SEC Filing on Google Icon
11/12/2025BIOS Capital Management LP10,049,996$67.23M75.6%+0.9%43.244%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.316,010$2.11M0.0%+19.5%1.360%Search for SEC Filing on Google Icon
11/3/2025New York State Common Retirement Fund6,200$41K0.0%-64.0%0.027%Search for SEC Filing on Google Icon
10/29/2025Northwestern University6,488$43K0.1%-76.6%0.028%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE15,292$93K0.0%+61,068.0%0.075%Search for SEC Filing on Google Icon
8/14/2025Voss Capital LP286,140$1.75M0.1%+101.0%1.398%Search for SEC Filing on Google Icon
8/13/2025New York State Common Retirement Fund17,200$0.11M0.0%N/A0.084%Search for SEC Filing on Google Icon
8/13/2025Northwestern Mutual Wealth Management Co.18,518$0.11M0.0%+492.6%0.090%Search for SEC Filing on Google Icon
8/12/2025BIOS Capital Management LP9,965,079$60.89M83.9%+0.7%48.681%Search for SEC Filing on Google Icon
8/12/2025Sfmg LLC14,550$89K0.0%+32.3%0.071%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC118,050$0.72M0.0%+252.5%0.577%Search for SEC Filing on Google Icon
7/17/2025Gleason Group Inc.19,028$0.12M0.0%N/A0.097%Search for SEC Filing on Google Icon
6/27/2025Goldman Sachs Group Inc.22,358$0.15M0.0%+98.7%0.114%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.22,358$0.15M0.0%+98.7%0.114%Search for SEC Filing on Google Icon
5/14/2025Voss Capital LP142,381$0.96M0.1%+157.7%0.729%Search for SEC Filing on Google Icon
5/9/2025Chicago Partners Investment Group LLC10,365$70K0.0%N/A0.053%Search for SEC Filing on Google Icon
5/9/2025Sfmg LLC11,000$74K0.0%N/A0.056%Search for SEC Filing on Google Icon
5/2/2025Sigma Planning Corp23,675$0.16M0.0%+47.3%0.121%Search for SEC Filing on Google Icon
2/17/2025OMERS ADMINISTRATION Corp10,583$84K0.0%N/A0.054%Search for SEC Filing on Google Icon
2/14/2025Mercer Global Advisors Inc. ADV16,344$0.13M0.0%N/A0.084%Search for SEC Filing on Google Icon
2/14/2025Voss Capital LP55,246$0.44M0.0%N/A0.283%Search for SEC Filing on Google Icon
2/13/2025Envestnet Asset Management Inc.10,465$83K0.0%N/A0.054%Search for SEC Filing on Google Icon
2/10/2025BIOS Capital Management LP9,893,651$78.75M83.7%N/A50.659%Search for SEC Filing on Google Icon
2/6/2025Freestone Capital Holdings LLC10,000$80K0.0%N/A0.051%Search for SEC Filing on Google Icon
2/3/2025Sigma Planning Corp16,075$0.13M0.0%N/A0.082%Search for SEC Filing on Google Icon
11/12/2024Northwestern University27,778$0.21M0.2%N/A0.142%Search for SEC Filing on Google Icon
10/29/2024KG&L Capital Management LLC12,000$89K0.0%N/A0.061%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Actuate Therapeutics logo
Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of cancers. The company's lead product candidate is Elraglusib Injection, a novel glycogen synthase kinase-3 inhibitor to treat metastatic pancreatic ductal adenocarcinoma. It also develops Elraglusib for the treatment of Ewing sarcoma, metastatic melanoma, and colorectal cancer. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. The company was incorporated in 2015 and is based in Fort Worth, Texas.
Read More on Actuate Therapeutics

Today's Range

Now: $7.35
Low: $7.23
High: $7.50

50 Day Range

MA: $6.85
Low: $5.85
High: $8.09

52 Week Range

Now: $7.35
Low: $5.47
High: $11.99

Volume

67,950 shs

Average Volume

54,759 shs

Market Capitalization

$170.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Actuate Therapeutics?

Actuate Therapeutics' top insider shareholders include:
  1. Equity Cof Lp Bios (Director)
  2. Todd S Thomson (Insider)
  3. Aaron GL Fletcher (Director)
  4. Leslie W Kreis (Director)
  5. Leslie W Kreis (Major Shareholder)
Learn More about top insider investors at Actuate Therapeutics.

Who are the major institutional investors of Actuate Therapeutics?

Actuate Therapeutics' top institutional shareholders include:
  1. BIOS Capital Management LP — 43.24%
  2. Voss Capital LP — 3.86%
  3. Vanguard Group Inc. — 1.36%
  4. Northwestern University — 0.03%
  5. New York State Common Retirement Fund — 0.03%
  6. Bank of America Corp DE — 0.02%
Learn More about top institutional investors of Actuate Therapeutics stock.

Which institutional investors are selling Actuate Therapeutics stock?

During the previous quarter, ACTU stock was sold by these institutional investors:
  1. Northwestern University
  2. New York State Common Retirement Fund
  3. Bank of America Corp DE

Which institutional investors are buying Actuate Therapeutics stock?

During the last quarter, ACTU stock was acquired by institutional investors including:
  1. Voss Capital LP
  2. BIOS Capital Management LP
  3. Vanguard Group Inc.
Within the previous year, these company insiders have bought Actuate Therapeutics stock:
  1. Equity Cof Lp Bios (Director)
  2. Todd S Thomson (Insider)
  3. Aaron GL Fletcher (Director)
Learn More investors buying Actuate Therapeutics stock.